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Abstract
Dynamic cerebral autoregulation (dCA) is impaired following stroke. However, the relationship between dCA, brain atrophy,
and functional outcomes following stroke remains unclear. In this study, we aimed to determine whether impairment of
dCA is associated with atrophy in specific regions or globally, thereby affecting daily functions in stroke patients. We
performed a retrospective analysis of 33 subjects with chronic infarctions in the middle cerebral artery territory, and 109
age-matched non-stroke subjects. dCA was assessed via the phase relationship between arterial blood pressure and
cerebral blood flow velocity. Brain tissue volumes were quantified from MRI. Functional status was assessed by gait speed,
instrumental activities of daily living (IADL), modified Rankin Scale, and NIH Stroke Score. Compared to the non-stroke
group, stroke subjects showed degraded dCA bilaterally, and showed gray matter atrophy in the frontal, parietal and
temporal lobes ipsilateral to infarct. In stroke subjects, better dCA was associated with less temporal lobe gray matter
atrophy on the infracted side (p=0.029), faster gait speed (p=0.018) and lower IADL score (pv0.002). Our results indicate
that better dynamic cerebral perfusion regulation is associated with less atrophy and better long-term functional status in
older adults with chronic ischemic infarctions.
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Introduction
Cerebral autoregulation (CA) modulates cerebral blood flow in
order to meet regional perfusion demands despite variations in
arterial blood pressure (BP) associated with daily activities [1].
Dynamic CA (dCA) refers to the rapid response of cerebral
vasculature to transient BP fluctuations. Several mechanisms are
involved in dCA, regulating cerebrovascular resistance through
dilation and constriction of cortical and pial arterioles [2].
Autoregulation is affected by age-related cerebro-microvascular
diseases such as hypertension [3] and diabetes [4], and is damaged
by ischemic stroke both acutely [5–8] and chronically [3].
Both impaired dCA [5,9], assessed in the acute stroke period,
and stroke-associated gray matter (GM) atrophy [10,11] are
associated with deficits in functional outcomes. However, the
impact of chronically impaired dCA on brain atrophy, as well as
its long-term effects on functional status in patients with ischemic
stroke, remain unknown. If post-stroke dCA directly impacts GM
atrophy and functional status, then interventions aimed at
improving dCA function may provide an additional modality for
clinicians to mitigate long-term functional deficits in stroke
patients.
Noninvasive assessment of dCA often entails examining the
coupling between continuous BP and cerebral blood flow velocity
(BFV), measured by transcranial Doppler ultrasound (TCD).
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quantification of this relationship is a challenge to reliable dCA
assessment. Multimodal pressure-flow (MMPF) analysis [3,12–15]
can better quantify the nonlinear relationship between non-
stationary BP and BFV signals than traditional transfer function
methods [14] using spontaneous BP-BFV fluctuations during
baseline conditions [13].
This study applied the MMPF-derived dCA measure to
examine the relationship between dCA, regional brain tissue
volumes, and functional status in a retrospective analysis of elderly
subjects with chronic large vessel infarctions in the middle cerebral
artery (MCA) territory, and in age-matched non-stroke subjects.
We hypothesize that worse perfusion regulation is associated with
enhanced gray matter atrophy in the temporal lobe, and worse
long-term functional status in the elderly with chronic ischemic
infarctions.
Methods
Experimental Protocals
Participants. All subjects signed informed consent and the
study was approved by the Institutional Review Board at Beth
Israel Deaconess Medical Center (BIDMC). Participants were
recruited from community advertisement, Beth Israel Deaconess
Medical Center, Joslin Diabetes Clinic patient registries and from
the Harvard Cooperative Program on Aging research subject
registry.
The data for this retrospective analysis of 142 subjects were
selected from a database of records prospectively collected at the
Syncope and Falls in the Elderly Laboratory and the Magnetic
Resonance Imaging Center at BIDMC. The database was
composed of records from three completed projects spanning
January 2002 to February 2008: Cerebral vasoregulation in the
elderly with stroke (March 2003–April 2005); Cerebral vasoregu-
lation in diabetes (January 2002–December 2005); and Cerebral
perfusion and cognitive decline in type 2 diabetes (January 2006–
December 2008). Grant numbers and awarding institutions are
provided in the financial disclosures section. All stroke subjects
included in the current project were recruited for the vasoregula-
tion in the elderly study while diabetic non-stroke subjects were
from the vasoregulation in diabetes and cognitive decline in
diabetes studies. Non-diabetic non-stroke subjects were recruited
in all three studies. The subjects were selected for the present
cohort, only if they completed both TCD and MRI measure-
ments, and met the inclusion/exclusion criteria detailed below and
in [4,16].
Included stroke subjects had large vessel hemispheric MCA
infarcts affecting v1/3 of the MCA territory documented by CT
or MRI during the acute event, defined according to the Trial of
ORG 10172 in Acute Stroke Treatment (TOAST) criteria [17]
after completion of diagnostic work up, i.e., patients with MCA
infarcts who had clinical and radiographic (duplex imaging or
arteriography) findings of either significant (w50%) stenosis or
occlusion of an appropriate extracranial (i.e., carotid) or intracra-
nial artery or branch cortical artery due to presumed atheroscle-
rosis. Diagnostic studies excluded potential sources of cardioem-
bolism. Clinical findings included those of cerebral cortical
impairment (aphasia, neglect, or restricted motor involvement).
A history of intermittent claudication, TIAs in the same vascular
territory, a carotid bruit, or diminished pulses was used to support
the clinical diagnosis. Infarcts greater than 1.5 cm in diameter on
CT or MRI were considered to be of potential large-artery
atherosclerotic origin. Subjects were required to be w6 months
post-stroke, in a clinically stable condition defined by a neurolog-
ical exam, NIH Stroke Scale (NIHSS) v5, and able to walk
unassisted (modified Rankin Scale (mRS)v4) upon admission to
the study.
All diabetic subjects were required to be diagnosed with type-II
diabetes mellitus (DM) and to have been treated for at least 1 year
prior to participation. Non-diabetic controls were age- and sex-
matched to diabetic and stroke subjects from their respective
studies with no clinical history of stroke and no focal deficits on
neurological examination. Non-diabetic participants were re-
quired to have normal fasting glucose.
Subjects were excluded if they had intracranial or subarachnoid
hemorrhage on MRI or CT or carotid artery stenosis (for control
group, over 50% by medical history and MR angiobgraphy and
for the stroke group, bilateral stenosis or stenosis contralateral to
stroke). Other exclusion criteria included myocardial infarction
within 6 months and other clinically important cardiac diseases;
arrhythmias; significant nephropathy; kidney or liver transplant;
renal or congestive heart failure; type I DM; or neurological or
other systemic disorders. Incompatibility with 3 Tesla MRI,
including claustrophobia, metal implants, pacemakers, and arterial
stents was also an excluding factor.
Collectively, the three studies recruited 358 subjects (157
healthy controls, 115 diabetic controls, 86 stroke). We excluded
145 subjects (71 healthy control, 33 diabetic control, 41 stroke)
because they either withdrew consent, they met exclusion criteria
(listed above), or they did not get permission from their primary
care provider. Of those subjects excluded, 24 subjects (14 healthy
controls, 8 diabetic controls, 2 stroke) were excluded due to a poor
temporal insonation window. From the remaining 213 subjects,
142 of them (52 healthy control, 57 diabetic control, 33 stroke) had
complete TCD and MRI recordings and were used for the final
analysis in the present study. Subjects with diabetes, hypertension,
or both were included as part of the non-stroke group in order to
control for dCA impairment associated with risk factors related to
stroke. Demographic information of the selected cohort is listed in
Table 1.
The stroke group consisted of 33 subjects that were 6.71+5.17
(mean + SE) years post acute event. The non-stroke group
consisted of 109 age- and sex-matched individuals. There were 23
stroke and 36 non-stroke (12 control, 24 diabetic) participants with
hypertension defined as receiving treatment for hypertension, or
average BPw140 or 90 mmHg on 24-hour ambulatory home
monitoring. There were 57 non-stroke participants receiving
treatment for type 2 diabetes mellitus for w5 years. Antihyper-
tensive medications were tapered and withdrawn for 3 days prior
to the study. Glycemic control medications were allowed.
Transcranial Doppler Studies. Experiments were conduct-
ed in the morning after a thirty-minute rest during instrumenta-
tion. Baseline recordings of 5–10 minutes were collected during
resting conditions when subjects were supine, awake and breathing
regularly at their normal respiratory frequency. Vasoreactivity to
CO2 (CO2R) was measured using 3 minutes of hyperventilation
followed by 3 minutes re-breathing 5% CO2 in an air bag.
Vasoreactivity was calculated as the slope of the regression of CO2
on BFV over baseline, hyperventilation, and rebreathing condi-
tions. BFVs in both MCAs were measured from trans-temporal
windows using TCD (MultiDop X4; Neuroscan, Sterling, VA). BP
was recorded from the finger using the volume-clamp technique
with a Finapres device (Finapres, Ohmeda Monitoring Systems,
Englewood, CO) and corroborated by sphygmomanometer
measurements. BP, BFV, respiration and end-tidal CO2 measure-
ments (Capnomac Ultima, Ohmeda Monitoring Systems, Engle-
wood, CO) were recorded at 500 HZ. Signals were decimated to
50 Hz before analysis.
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MRI studies were performed on a 3-Tesla GE Signa Vhi or Excite
MRI scanner using a quadrature and phase array head coils (GE
Medical Systems, Milwaukee, WI). Anatomical 3D magnetization
prepared rapid gradient echo (MP-RAGE) images were used to
quantify brain volumes with the Statistical Parametric Mapping
software (SPM, University College,A London, UK) using spatial
normalization and tissue classification. An anatomical template
(Laboratory of Neuro Imaging, University of California, Los
Angles, USA) was applied to measure GM and white matter (WM)
in frontal, temporal, parietal, and occipital lobes. Normalized
volumes (regional volume/global intracranial volume, cm
3/cm
3)
of GM, and WM were used for analysis. Vessel diameters were
derived from 3D MR angiography (time of flight, TOF) using the
Medical Image Processing, Analysis, and Visualization (MIPAV)
software from the Biomedical Imaging Research Services Section,
NIH, Bethesda, MD, at 3 locations and averaged. Diameters
Internal carotid arteries (ICA) and MCAs were computed from a
single-slice transverse view with conservatively estimated accuracy
(+0.4 mm), based on the image resolution.
Functional Status. Functional status was assessed in both
stroke and non-stroke groups by gait speed (measured by a 12-
minute walking test at preferred walking speed), Instrumental
Activities of Daily Living [18] (IADL) survey, and the Mini Mental
State Exam (MMSE). The stroke group was also assessed by
NIHSS, and mRS.
Data Analysis
Cerebral autoregulation. Multimodal pressure-flow
(MMPF) analysis was used for non-invasive assessment of dCA.
Details on the development and performance of the method have
been published previously [3,12,13].
The MMPF analysis for this study was performed according to
the following four major steps:
1. Decomposition of BP and BFV signals into multiple empirical
modes.
Central to the MMPF method is the Hilbert-Huang transform
[19]. This approach decomposes the original signal into
empirical modes by a ‘‘sifting’’ algorithm [20] which adaptively
extracts narrow-band, zero mean (but not necessarily station-
ary) components of the original BP and BFV time series.
2. Selection of empirical modes for dominant oscillations in BP at
0.1–0.3 Hz and corresponding oscillations in BFV.
In order to determine a meaningful phase relationship between
the BP and BFV time series, empirical modes from both series
must be selected from within the same frequency band.
Previous studies have shown that dCA can be assessed from
respiratory-induced pressure-flow variations during spontane-
ous respiration [12,13,21,22]. Therefore, the modes used for
further analysis were selected in order to correspond to the
respiratory frequency range of 0.1–0.3 Hz.
3. Calculation of instantaneous phases of extracted BP and BFV
oscillations.
Since each empirical mode has zero mean and is sufficiently
narrow-band, the complex part of each mode can be calculated
by the Hilbert transform [19]. The instantaneous phase of BP
or BFV oscillations is obtained from the inverse tangent
transform of the ratio of the real and complex parts of the
signal.
4. Calculation of the mean BP-BFV phase difference (Dw), as the
dCA measure.
The arithmetic mean of the difference in the phases of
extracted BP and BFV oscillations was calculated and served as
the metric by which we assessed dCA. Larger Dw corresponds
to better dCA function [3,21,22].
Statistical Analysis. For all subjects, MRI and TCD
measurements were made on both left and right sides and analyses
were conducted by stroke side and non-stroke side. Since non-
stroke subjects did not have an affected side, each non-stroke
subject was randomly assigned a O ` strokeO ´ side (RND1) and a
Table 1. Demographic and group summary statistics.
Stroke Control p-value
Age (years) 63.4+1.4 65.3+0.8 0.23
Male/Female 19/14 61/48 0.87
Race (W/A/AI/AA/U) 29/1/0/3/0 93/8/1/6/1 0.01
*
Smokers (Y/N) (Current,Past) (8/25), (28/5) (4/72), (42/67) v.01
*,v.01
*
Packs per year 33.0+5.3 6.9+1.4 v.01
*
stroke side (R/L)(M,F) (11/8),(7/7) (38/23),(25/23) 0.74
Hypertens./Normotens. 23/10 36/73 v0.01
*
Diabetes Mellitues (M/F) 0/0 35/22 –
Mean BP (mmHg) 87+28 4 +1 0.23
Systolic BP (mmHg) 131+31 2 4 +2 0.02
*
Diastolic BP (mmHg) 63+26 2 +1 0.69
Body mass index (kg/m2) 27.7+0.8 26.7+0.4 0.29
Gait Speed (m/s) 0.88+0.03 1.1+0.02 v.01
*
IADL (counts per score) (6,10,4,7) (33,21,3,2) v.01
*
Mini mental state exam 26.7+2.6 27.6+1.9 0.03
*
NIH stroke scale 2.5+2.6 – –
mRS (counts per 0,1,2,3,4) (11,13,3,4,0) – –
BFV (NS/RND2) (cm/s) 39.4+3.3 45.1+2.0 0.15
BFV (SS/RND1) (cm/s) 40.8+3.5 45.2+2.1 0.29
Dw (NS/RND2) (degrees) 7.3+3.3 14.9+1.9 0.02
*
Dw (SS/RND1) (degrees) 4.4+3.4 12.8+1.9 0.02
*
CO2R (SS/RND1) 0.18+0.79 0.88+0.49 0.45
CO2R (NS) 0.94+0.92 1.28+0.56 0.75
End-tidal CO2 (mmHg) 35.4+0.7 36.7+0.4 0.09
MCA (SS/RND1)(mm) 2.27+0.13 2.59+0.05 0.02
*
MCA (NS/RND2)(mm) 2.44+0.11 2.58+0.04 0.27
ICA (SS/RND1) (mm) 5.18+0.22 5.3+0.08 0.61
ICA (NS/RND2) (mm) 5.18+0.17 5.3+0.07 0.51
White blood cells (k/ul) 6.96+0.38 6.62+0.16 0.37
Hemoglobin (g/dL) 13.8+0.2 13.6+0.1 0.60
Hematocrit (%) 40.1+0.7 40.1+0.4 0.98
Cholesterol 179+71 9 0 +4 0.19
LDL (mg/dL) 95+61 0 0 +3 0.42
triglycerides (mg/dL) 147+16 166+11 0.40
infarct (volume/ICV)*100 2.25+.43 – –
Values are mean + SE or number of subjects.
*indicates stroke and control groups are significantly different after controlling
for false discovery rate. Abbreviations: W=white; A=Asian; AI=American
Indian; AA=African American; U=unknown; R/L=right/left; M/F=male/female;
IADL=instrumental activities of daily living; mRS=modified Rankin scale;
BP=blood pressure; BFV=blood flow velocity; Dw=BP-BFV phase difference;
CO2R=CO 2 reactivity; MCA=middle cerebral artery diameter; ICA=internal
carotid artery diameter; ICV=intracranial volume; SS/RND1=Stroke side; NS/
RND2=non-stroke side; LDL=Low density lipoprotein.
doi:10.1371/journal.pone.0046794.t001
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ed in order to have a left-side-stroke/right-side-stroke probability
that approximately matched the distribution of the stroke group.
Univariate group differences were determined by one -, or two-
tailed t-test, or x2 test where appropriate. Within-group differences
between sides in brain volumes, blood flow velocity, the dCA
measure (Dw), and ICA and MCA diameters were determined by
1-sided Wilcoxon signed-rank test.
To constrain the number of variables under consideration,
regression analyses were limited to those areas directly affected by
stroke (i.e. MCA territory on the stroke side/RND1). Linear
regression models were tested for the effects of Dw on GM
volumes, Dw on functional measures and GM volumes on
functional measures. With each model, we examined the primary
independent variable (either Dw or GM volume) was examined for
a significant effect separately for stroke and non-stroke subjects.
Regression parameters were estimated using the traditional least
squares estimator as well as the Theil-Sen robust regression
estimator [23,24] with outlier skipping by the orthogonal
projection method (TSOP). This robust regression estimator
down-weights response outliers and high leverage points observed
in our data [25].
Robust regression parameter inference, including simultaneous
95% confidence intervals and hypothesis test statistics, was
estimated by bootstrapping of observations. For each robust
regression, bootstrapping consisted of n=600 resamples of the
stroke group, with replacement, of the multivariate observations.
Regression parameter estimates, standard errors, bootstrap
confidence intervals, and hypothesis test statistics were calculated
using functions written by R.R. Wilcox [25] in the rallfun.v-14
package (downloaded from www-rcf.usc.edu/rwilcox/ on 6/19/
11) for the statistical computing software R [26]. The Theil-Sen
estimates were calculated using the tsreg() function embedded
within the opreg() function. Bootstrap confidence intervals were
calculated using the regci() function. Default settings were used for
all functions. Linear models for robust regression controlled for
age, mean blood pressure, sex, BMI and infarct volume.
Relationships between GM and IADL and between Dw and
IADL were tested by logistic regression. The IADL scores w3,
which were present in 7 subjects, were grouped into a single
category. Statistical control variables were included based on the
presence of significant correlations with brain matter volumes,
functional status measurements or Dw. The resulting models were
adjusted for age, sex, mean BP, infarct volume, and body mass
index (BMI).
For groups of hypothesis tests that included multiple variables
(differences between groups and between sides), the threshold of
significance was adjusted to maintain a false discovery rate [27] of
0.05. Statistical inference was computed in JMP (SAS Institute.
Cary, NC, USA).
Results
Effects of stroke on functional status, brain volumes, and
dCA
Demographic characteristics, mean BP, MCA and ICA
diameters on the non-stroke side, mean BFV and CO2
vasoreactivity and laboratory results were similar between the
stroke and non-stroke groups (Table 1). Stroke subjects had worse
scores on performance and cognitive measures (IADL p~0:0015,
MMSE p~0:03) and slower gait speed (pv0:0001). In stroke
subjects, frontal, temporal and parietal lobe volumes were
significantly smaller on the stroke side as compared to the non-
stroke side, and to the RND1 and RND2 sides of non-stroke
subjects (Table 2). Mean BFV and CO2 vasoreactivity was not
significantly different between sides within either group. There
were no significant differences in any measures between the
RND1 and RND2 sides of non-stroke subjects.
BP-BFV phase shift (Dw) was smaller in stroke subjects
compared to non-stroke subjects (Table 1, stroke side: p~0:016;
non-stroke side: p~0:023), but was not different between stroke
and non-stroke sides. In the non-stroke group, non-diabetic
subjects had larger Dw than diabetic subjects (RND1:
p~0:0016; RND2: p~0:0006), who had similar Dw to stroke
subjects. BP-BFV phase shift was not significantly associated with
age; mean, systolic, or diastolic BP; hypertension diagnoses or
treatment; mean BFV; CO2 vasoreactivity; left/right stroke side;
glucose levels; hematocrit; hemoglobin A1C levels; BMI; ICA or
MCA diameters; total cholesterol, LDL or triglycerides.
The fraction of subjects with either current or previous smoking
history was significantly different for stroke and non stroke groups
(Table 1). Neither smoking status nor packs per year (pack years)
were significantly correlated (pw:05) with gait speed, Dw or GM
volumes. Therefore, smoking data was not included in further
analyses.
Associations between dCA, regional brain volumes, and
functional status
The main results for least squares regressions are summarized in
Table 3, and for robust regressions in Table 4.
Pressure-flow phase shift and brain volume. Using least
squares regression, a larger Dw was associated with larger temporal
lobe GM volume in stroke subjects (model fit: adjusted R2
(R2
adj)=0.73, pv0:0001, effect test: t-ratio ~2:32, p~0:0292)
after controlling for age, sex, mean BP, BMI, and infarct volume,
but not in non-stroke subjects (model fit: R2
adj~0:16, p~:0013,
Effect test: t-ratio ~{0:023, p~0:82). The relationship between
Dw and temporal lobe GM, independent of age, sex, mean BP,
BMI, and infarct volume is shown in Fig. 1. There were no
significant associations between Dw and temporal WM or between
Dw and GM or WM volumes in frontal, parietal, or occipital
regions.
In agreement with the least squares estimates, the Theil-Sen
estimates showed a significant effect (p=0.047) of Dw on temporal
lobe GM for stroke subjects (Table 4) after controlling for age, sex,
Table 2. Brain volumes by region and side.
Stroke Group Control Group
Region S side NS side RND1 RND2
Front. GM 5.2+0.10 5.6+0.09
* 5.5+0.05
* 5.5+0.05
Temp. GM 4.4+0.07 4.7+0.06
* 4.6+0.04
* 4.7+0.03
Par. GM 3.0+0.06 3.2+0.05
* 3.2+0.03
* 3.2+0.03
Occ. GM 1.8+0.03 1.8+0.03 1.8+0.02 1.8+0.02
Temp. WM 2.0+0.04 2.1+0.05
* 2.1+0.02
* 2.1+0.03
Front.WM 4.1+0.10 4.5+0.09
* 4.4+0.06
* 4.4+0.05
Par. WM 2.5+0.06 2.6+0.06
* 2.7+0.03
* 2.7+0.03
Occ. WM 1.7+0.03 1.1+3.13
* 1.8+0.03 1.8+0.03
Gray matter (GM) and white matter (WM) volumes for stroke (S) and non-stroke
(NS) groups by side. Values are mean+SE.
*indicates values are significantly different from stroke side of stroke group by
Wilcoxon signed-rank test, with false discovery rate of 0.05.
doi:10.1371/journal.pone.0046794.t002
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Pressure-flow phase shift and functional status. Using
the least squares estimator, a larger Dw was associated with faster
gait speed for stroke subjects (model fit: R2
adj~0:59, pv0:0001,
Effect test: t-ratio ~2:55, p~0:018) after controlling for age, sex,
mean BP, BMI, and infarct volume, but not for non-stroke subjects
(model fit: R2
adj~0:001, p~0:41, Effect test: t-ratio ~{0:19,
p~0:85). The relationship between Dw and gait speed, indepen-
dent of age, sex, mean BP, BMI, and infarct volume is shown in
Fig. 2A.
The Theil-Sen estimate for the relationship between Dw and
gait speed did not meet the threshold for a significant effect, but
was found to be marginally significant (p=0.097, Table 4) when
controlling for age, sex, mean BP, BMI and infarct volume. The p-
value of the test was considerably reduced (p=0.067) when infarct
volume was not included in the regression.
Ordinal logistic regression showed that a larger Dw was
associated with a better daily functionality (i.e., lower IADL) for
stroke subjects (Lack of fit: x2~55:62, p~0:88, Effect likelihood
ratio test: x2~9:207, p~0:002) (Fig. 2B) after controlling for age,
sex, mean BP, BMI and infarct volume but there was no
significant association between Dw and IADL in non-stroke
subjects (Lack of fit: x2~78:86, p~0:99, Effect likelihood ratio
test: x2~0:11, p~0:74). No associations were found between Dw
and MMSE, mRS or NIHSS.
Regional brain volumes and functional status. In con-
trast with our findings of associations between Dw and temporal
GM, and between Dw and functional status in stroke subjects, no
significant associations were found between temporal GM and gait
speed (model fit: R2
adj =0.51, p=0.0004, Effect test: t-ratio ~1:51,
p~0:1454) after controlling for age, sex, mean BP, BMI and
infarct volume using the least squares estimator. However, faster
gait speed was associated with larger temporal lobe GM volumes if
infarct volume was not included in the regression equation for
both stroke (model fit: R2
adj =0.62, pv0:0001, Effect test: t-ratio
~5:56, pv0:0001) and non-stroke (model fit: R2
adj =0.12,
p~0:0117, Effect test: t-ratio ~3:21, p~0:002) subjects. This
effect was significantly stronger in stroke subjects than for non-
stroke subjects (Effect test of interaction: t-ratio ~{2:44,
p~0:0165).
Similar to our results with least squares regression, the Theil-
Sen estimate for a relationship between gait speed and temporal
GM was marginally significant, (p=0.08) when infarct volume was
included, with a smaller p-value (p=0.06) when infarct volume
was not included.
IADL was not significantly associated with temporal GM (Lack
of fit: x2~62:76, p~0:69, Effect likelihood ratio test: x2~1:93,
p~0:16) after controlling for age, sex, mean BP, BMI and infarct
volume. However, larger temporal lobe GM on the stroke side was
associated with better functionality (i.e. lower IADL) for stroke
subjects (Lack of fit: x2~145:29, p~0:69, Effect likelihood ratio
test: x2~9:02, p~0:003) but not for non-stroke subjects (Lack of
fit: x2~78:86, p~0:99, Effect likelihood ratio test: x2~0:11,
p~0:74). Brain volumes were not associated with MMSE or
NIHSS.
Regional brain volumes, gait speed, and infarct
volume. In order to examine the confounding effect of infarct
volume on linear regressions observed above, linear regressions of
infarct volume on gait speed and temporal lobe GM were
examined, after correcting for age, sex, mean BP and BMI. Least
squares regression showed that larger infarct volumes were
associated with significantly slower gait speed (model fit:
R2
adj =0.505, p~0.0004, Effect test: t-ratio=25.31, pv0.0001)
and smaller temporal GM volumes (model fit: R2
adj =0.68,
pv0.0001, Effect test: t-ratio=27.93, pv0.0001). On the other
hand, robust regression showed only a modest effect of infarct
volume on temporal GM (p=0.077) and none for gait speed
(p=0.51).
Discussion
This study examined the relationships among dCA, brain
structural volumes, and functional status in subjects with chronic
ischemic stroke using a nonlinear dCA assessment computed using
the MMPF method. Both traditional least squares regression and
Table 3. Least-squares results for model fit, and effect tests for Dw.
Response Predictor Group Model fit Effect test
TGM Dw Stroke R2
adj~0:73, pv0:0001 t-ratio ~2:32, p~0:0292
Non-stroke R2
adj~0:16, p~:0013 t-ratio ~{0:023, p~0:82
Gait Dw Stroke R2
adj~0:59, pv0:0001 t-ratio ~2:55, p~0:0178
Non-stroke R2
adj~0:001, p~0:41 t-ratio ~{0:19, p~0:85
IADL Dw Stroke x2~55:62, p~0:88 x2~9:207, p~0:002
Non-stroke x2~78:86, p~0:99 x2~0:11, p~0:74
Regression on temporal lobe grey matter (TGM), gait speed (Gait), instrumental activities of daily living survey (IADL). Estimates were calculated with regression
equations controlling for age, BMI, mean arterial pressure, sex, and infarct volume. The x2 tests for IADL correspond to lack of fit, and likelihood ratio tests.
doi:10.1371/journal.pone.0046794.t003
Table 4. Robust regression bootstrap estimates.
Response Predictor Estimate S.E. p-value
TGM Dw 6.8|10{5 3.97|10{5 0.047
Gait Dw 4.05 |10{3 3.04|10{3 0.097
Gait TGM 30.0 23.0 0.080
Gait TGM
* 28.9 14.7 0.060
Theil-Sen estimates for regressions with Dw, temporal lobe gray matter volume
(TGM), and gait speed (Gait) for stroke subjects. Estimates were calculated with
regression equations controlling for age, BMI, mean arterial pressure, sex, and
infarct volume.
*indicates results without controlling for infarct volume.
doi:10.1371/journal.pone.0046794.t004
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function is associated with less GM atrophy and better functional
status. Supporting this hypothesis, smaller Dw was associated with
smaller temporal lobe GM, slower gait speeds, and higher IADL
(lower function), independent of age, sex, mean BP, and BMI.
Clinical implications
Poor clinical outcomes have been shown to be associated with
impaired dCA following both brain injury [28–30] and acute
ischemic stroke [5,9]. This study presented evidence indicating
that not only is worse functional status post-stroke concomitant
with impaired dCA, but the degree of dCA impairment is
negatively correlated with functional performance (Fig. 2).
Atrophy of brain tissue continues following the acute stroke
period and extends from periinfarct zones to contralateral and
remote cortical and subcortical regions that are functionally
connected to the infarct site [31]. Supporting this notion are
findings of impaired vascular reactivity in regions distant from the
infarct site in patients with chronic ischemic infarctions [16]. We
also noted a consistent pattern of GM atrophy, independent of the
specific infarct location, in the ipsilateral frontal, parietal and
temporal lobes extending beyond the affected MCA territory
(Table 2).
Both impaired CA [9] and GM atrophy [10,11] following stroke
have been associated with cognitive impairment. Therefore,
chronic impairment of autoregulation may affect perfusion
redistribution during daily activities [4,32–34], contributing to
GM atrophy and influencing long-term recovery after stroke.
In the present study, although all MCA-territory brain regions
showed significant atrophy for stroke subjects, the relationships
between dCA impairment, GM atrophy, and functional status
were most prominent for temporal lobe GM. These relationships
were not observed in age-matched, diabetic, or non-diabetic non-
stroke subjects, and were independent of BP. However, diabetic
subjects also had impaired dCA compared to healthy nonstroke
subjects, which suggests that associations between dCA, functional
impairment, and temporal lobe GM are stroke-specific and not
due to normal aging or stroke-independent dCA impairment.
Temporal lobe structures such as the insular cortex and
amygdala are key centers of the autonomic network [35], playing
a role in vascular resistance and sympathetic modulation of dCA
[36]. Both autoregulation [3,6–8] and autonomic regulation
[37,38] are altered following stroke, and sympathetic activity has
been shown to affect dCA [39], although its precise role is
contended [40,41]. Damage to the insular cortex in particular is
associated with autonomic dysfunction [35,36,42] and poor long-
term prognosis [42] in stroke subjects. Medial temporal lobe
atrophy is also associated with greater incidence of post-stroke
Figure 1. Effect of Dw on temporal lobe gray matter volume.
Residuals of least squares regression on relative temporal lobe gray
matter (GM) volume against BP-BFV phase difference (Dw). Regression
included age, BMI, mean BP, sex and infarct volume for stroke side of
the stroke group plotted against blood pressure-blood flow velocity
(BP-BFV) phase difference for stroke (A) and non-stroke (B) sides. Cyan
lines indicate least squares regression line for BP-BFV phase difference
on temporal GM residuals in stroke subjects, and 95% prediction
interval.
doi:10.1371/journal.pone.0046794.g001
Figure 2. Effect of Dw on functional status. A: the residuals from
least squares regression of age, BMI, mean BP, sex and infarct volume
for stroke side of the stroke group, on gait speed plotted against stroke-
side blood pressure-blood flow velocity (BP-BFV) phase difference. Cyan
lines indicates least squares regression for BP-BFV phase difference on
gait speed residuals in stroke subjects and 95% prediction interval. B:
BP-BFV phase difference for stroke and non-stroke subjects as a
function of score on the instrumental activities of daily living (IADL)
survey. Error bars indicate standard error.
doi:10.1371/journal.pone.0046794.g002
dCA, Brain Atrophy, and Outcomes in Stroke
PLOS ONE | www.plosone.org 6 October 2012 | Volume 7 | Issue 10 | e46794dementia [11]. Thus, temporal lobe atrophy may persistently
affect dCA via its influences on autonomic function, in addition to
its more direct effects on functional performance. A more detailed
analysis of the temporal lobe structures is needed to determine if
specific regions of the temporal lobe are responsible for its role in
the dCA -temporal GM-functional status relationship found in the
current study.
Disrupted autonomic regulation after stroke may also influence
the clinical outcomes measured in this study, independent from
dCA. Sympathetic reflex activity is attenuated with chronic stroke
and this attenuation is correlated with functional motor capacity
[43]. Similarly, pathological sympathetic activity has been shown
to be associated with poor long-term outcomes in subjects with
thromboembolic stroke [42]. The potential role of autonomic
function on the dCA - brain atrophy - functional outcomes
relationship should be directly examined in stroke subjects. In this
regard, future studies should consider BP-BFV coupling over
frequency bands more directly associated with autonomic activity
[44].
We hypothesize that treatments aimed at the improvement of
dCA may play a role in optimizing the functional performance
and quality of life in elderly people with chronic ischemic stroke.
Therefore, the dCA status and the potential effects of treatments
(such as antihypertensive medications [45,46]) on dCA function
and functional outcomes should be considered in the overall
treatment strategy for patients with chronic stroke. For example,
angiotensin receptor blockers (ARB’s) have been shown to prevent
vascular dementia in elderly subjects [47] and brain atrophy in
hypertensive subjects [48], and they are significantly more effective
at preventing stroke in hypertensive patients than other blood-
pressure-lowering medications [49]. They have not been shown to
lower risk of recurrent stroke, however, [50]. Since some
component of the neuroprotective effects of ARBs may be
independent of their BP-lowering effects [51,52], the neuropro-
tective effects of ARBs may be acting through their ability to
improve autoregulatory function. Therefore if, as the present study
suggests, there is a connection between dCA, brain atrophy and
functional status following stroke, treatment with ARBs may be an
effective strategy for stroke patients to preserve functional status,
even in the absence of hypertension. While ARB’s have been
shown to improve static cerebral autoregulation in hypertensive
rats [53], investigations of the effects of ARBs on dCA are needed.
Limitations
The results of least squares regression were in agreement with
robust regression estimates for the relationship between Dw and
temporal lobe GM. However, in part due to the presence of
outliers, the associations between Dw and gait speed were more
tenuous, and the correlation between temporal lobe GM and gait
speed was only marginally significant based on robust regression.
The latter results are surprising, as degree of GM atrophy is known
to coincide with degree of functional impairment. For instance,
Lee et al:[54] demonstrated that brain atrophy negatively impacts
functional recovery, as measured by mRS, where ‘‘acceptable’’
outcomes were operationalized as mRS ƒ4. In the current study,
mRS v4 was a necessary condition of inclusion. The Lee et al:
sample also included individuals with more severe strokes than in
the current study, as measured by NIHSS. Furthermore, the
number of participants with IADL scores larger than 2 was limited
in our study. Therefore, a larger prospective study that draws upon
subjects from a population-based sample of people with various
types of strokes may be beneficial to verifying the findings of this
study.
Including infarct volume in the linear models had a consider-
able effect on robust regression results. When including infarct
volume, the regressions of Dw on gait speed and temporal lobe
GM on gait speed were marginally significant (0.05vpv0.1)
These associations were somewhat stronger when infarct volume
was excluded from the models (pv0.07 for both). Robust
regression estimators tend to have poor asymptotic efficiency
[25]. Consequently, the small sample size of this study makes our
results susceptible to type II error, particularly with a larger
number of covariates. Thus, the efficiency of the estimator may
help explain the impact of infarct volume on the models in spite of
the lack of a robust association between gait speed and infarct
volume (p=0.51). Therefore, we view our results with both the
least squares and robust regression estimators to be in support of
our hypothesis that there is an interaction between dCA, brain
atrophy, and functional status following stroke, although we
concede that studies with larger and more diverse samples of
stroke subjects are necessary in order to verify our results.
The size and variability of the sample may also explain why no
significant differences in CO2 reactivity between groups were
detected (Table 1). In agreement with previous findings of
depressed CO2 reactivity for stroke subjects [55], the group mean
of CO2 reactivity was lower in stroke subjects than in non-stroke
subjects. However, the between-group difference was not signif-
icant due to the large standard errors within both groups.
Due to the retrospective nature of the present study, the sample
selected for analysis was not population-based. Specifically, our
non-stroke group included individuals with diabetes, hypertension,
or both while all stroke subjects were non-diabetic. However,
diabetes is a major risk factor for stroke and hypertension [56,57].
Cardiovascular risk factors, such as hypertension and diabetes are
known to alter endothelial function and have adverse effects on
cerebral vasoreactivity. Both diabetes and hypertension are shown
to degrade dCA [3,22], and dCA was impaired in diabetic subjects
in the present study. Importantly, recent work has suggested that
impairment of CA precedes stroke [58,59]. Inclusion of individuals
with risk factors for stroke (e.g., DM and hypertension) within the
control group, but not in the stroke group, allowed us to determine
the extent to which our results were a reflection of the interactions
between dCA impairment and effects due to stroke versus the
interactions between dCA impairment, stroke and effects due to
cardiovascular risk factors that are predictive of stroke. Thus, it is
conceivable that preexisting impairment of CA may influence GM
atrophy and functional recovery following stroke. Leveraging the
notion that dCA impairment precedes stroke, we may posit that
impairment of dCA may alter neurovascular coupling in GM, thus
making the stroke-affected regions vulnerable to transient cerebral
blood flow fluctuations, and altering processes governing connec-
tivity for neuroregeneration and functional recovery. Future work
should include the analysis of a population-based sample of larger
size.
The study design has also limited the elucidation of causality
between impaired cerebral autoregulation, brain tissue loss and
poor functional outcomes in stroke patients. Since stroke itself can
cause impairment of dCA, brain tissue loss and worse functional
outcomes, the cross-sectional study design cannot demonstrate a
causal link between dCA, tissue loss and functional outcome.
Therefore, future work should include a longitudinal study that
would evaluate the time course and relationship between cerebral
autoregulation and functional outcomes.
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There are likely associations between dCA, temporal lobe GM,
gait speed, and IADL, indicating that dCA may impact GM
atrophy and functional recovery following stroke. The relation-
ships between dCA, temporal lobe GM and functional status were
independent of age, sex, BMI, mean BP and mean BFV, but it is
unclear how infarct volume is associated with these parameters.
Therefore, dCA impairment may be an important factor
underlying perfusion adaptation to daily activities and progression
of regional atrophy and functional recovery in patients with stroke.
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